Global Gene Synthesis Market Report and Forecast 2023-2031
Market Report I 2023-07-04 I 140 Pages I EMR Inc.
Global Gene Synthesis Market Report and Forecast 2023-2031
Global Gene Synthesis Market Outlook
The global gene synthesis market attained a value of USD 2 billion in 2022, driven by increasing demand for customized genes and advancements in gene synthesis technologies. The market is expected to grow at a CAGR of 21.18% during the forecast period of 2023-2031 to attain a value of USD 10.2 billion by 2031.
Gene Synthesis: Introduction
Gene synthesis is a laboratory technique that involves artificially creating DNA sequences corresponding to specific genes or genetic elements. It allows to produce custom-designed DNA molecules with precise nucleotide sequences. Gene synthesis has numerous uses and offers several benefits in various fields of research and applications.
The uses of gene synthesis include:
- Gene Function Studies: Gene synthesis enables the production of specific DNA sequences for studying gene function and understanding biological processes. Scientists can design and synthesize genes of interest to investigate their roles in cellular functions, disease mechanisms, and developmental processes.
- Protein Expression and Engineering: Gene synthesis plays a vital role in protein expression and engineering. By synthesizing genes encoding desired proteins, researchers can optimize protein expression levels, modify protein sequences to enhance stability or functionality, and generate variants for structure-function studies or therapeutic applications.
- Vaccine Development: Gene synthesis is used in the development of vaccines. Researchers can synthesize genes encoding viral or bacterial antigens, enabling the production of recombinant proteins or DNA vaccines for immunization studies and vaccine development against infectious diseases.
- Genetic Engineering and Biotechnology: Gene synthesis is fundamental in genetic engineering and biotechnology. It enables the creation of recombinant DNA constructs, synthetic gene circuits, and engineered genetic pathways for various applications such as metabolic engineering, biofuel production, biopharmaceutical production, and bioremediation.
- Synthetic Biology: Gene synthesis is at the core of synthetic biology, allowing scientists to design and build artificial gene networks, genetic circuits, and entire synthetic genomes. This field aims to engineer novel biological systems with desired functions and properties, leading to applications in biotechnology, bioengineering, and even the creation of synthetic organisms.
The benefits of gene synthesis include:
- Customization and Design: Gene synthesis offers customization and design flexibility, allowing researchers to create DNA sequences with precise nucleotide sequences. This enables the generation of genes optimized for specific applications, incorporating desired modifications, codon usage preferences, regulatory elements, or other functional elements.
- Time and Cost Efficiency: Gene synthesis provides a more efficient and cost-effective alternative to traditional cloning methods for obtaining specific DNA sequences. It eliminates the need for time-consuming and labour-intensive cloning steps, reducing research and development timelines and costs associated with gene manipulation.
- Access to Rare or Non-Natural Genes: Gene synthesis allows access to rare or non-natural genes that may be difficult to obtain from natural sources. Researchers can synthesize genes from diverse organisms, obtain genes with rare codon usage patterns, or design non-natural genetic sequences to explore new functions or properties.
- Error Correction and Optimization: Gene synthesis technologies include error correction mechanisms to ensure high-quality DNA sequences. This minimizes sequence errors, mutations, or other artifacts commonly encountered in traditional cloning approaches, leading to more reliable and reproducible results.
- Accelerated Research and Innovation: Gene synthesis accelerates research and innovation by providing quick access to customized DNA sequences. Researchers can rapidly obtain genes of interest, allowing them to focus on downstream experiments, hypothesis testing, and advancing scientific discoveries or product development.
It is important to note that ethical considerations, biosafety guidelines, and intellectual property regulations should be followed when utilizing gene synthesis techniques, especially in applications involving genetically modified organisms or potential biohazards.
Gene Synthesis Market Segmentations
The market can be categorised into components, gene therapy, application, synthesis type, and region.
Market Breakup by Components
- Synthesizer
- Consumables
- Software and Services
Market Breakup by Gene Therapy
- Standard Gene
- Express Gene
- Complex Gene
- Others
Market Breakup by Application
- Synthetic Biology
- Genetic Engineering
- Vaccine Design
- Therapeutics Antibodies
- Others
Market Breakup by Gene Synthesis Type
- Gene Library Synthesis
- Solid Phase Synthesis
- Chip-Based DNA Synthesis
- PCR-Based Enzyme Synthesis
Gene Synthesis Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Gene Synthesis Market Overview
The gene synthesis market has experienced significant growth and is projected to continue expanding in the coming years. Several factors contribute to the positive market scenario.
One of the primary drivers of market growth is the increasing demand for synthetic genes in various fields of research and applications. Advancements in genetic engineering, biotechnology, and synthetic biology have led to a growing need for custom-designed DNA sequences. Gene synthesis enables researchers to obtain specific genes with precise nucleotide sequences, facilitating studies on gene function, protein expression, vaccine development, genetic engineering, and synthetic biology. The expanding applications of gene synthesis across these fields drive market demand.
Moreover, technological advancements in gene synthesis techniques have played a crucial role in market expansion. The development of high-throughput synthesis platforms, improved error correction mechanisms, and optimization algorithms has enhanced the efficiency, accuracy, and scalability of gene synthesis. These advancements have reduced turnaround times, improved sequence quality, and lowered costs, making gene synthesis more accessible and appealing to researchers and industry professionals.
In conclusion, the gene synthesis market is poised for significant growth due to the increasing demand for custom-designed DNA sequences, technological advancements, the availability of gene synthesis services, and the expanding applications in genetic engineering and synthetic biology. As the need for rapid access to customized genes and synthetic DNA sequences continues to rise, there will be a focus on further improving synthesis efficiency, reducing costs, and expanding the range of available gene synthesis services. Continued investment in research and development, advancements in synthesis technologies, and collaborations between industry and academia will shape the future of the gene synthesis market.
Key players in the global gene synthesis Market
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the gene synthesis market are as follows:
- ATDBio Ltd
- General Biosystems
- Macrogen CO.
- Boster Biological Technology
- Creative Biogene
- Bioneer Pacific,
- Exonbio
- trenzyme GmbH
- Twist Bioscience
- BioCat GmbH
- OriGene Technologies, Inc.
- Integrated DNA Technologies
- Eurofins Scientific
- NZYTech
- Genes and Enzymes
*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Gene Synthesis Market Overview
3.1 Global Gene Synthesis Market Historical Value (2016-2022)
3.2 Global Gene Synthesis Market Forecast Value (2023-2031)
4 Global Gene Synthesis Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter's Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Gene Synthesis Market Segmentation
5.1 Global Gene Synthesis Market by Components
5.1.1 Market Overview
5.1.2 Synthesizer
5.1.3 Consumables
5.1.4 Software and Services
5.2 Global Gene Synthesis Market by Gene Therapy
5.2.1 Market Overview
5.2.2 Standard Gene
5.2.3 Express Gene
5.2.4 Complex Gene
5.2.5 Others
5.3 Global Gene Synthesis Market by Application
5.3.1 Market Overview
5.3.2 Synthetic Biology
5.3.3 Genetic Engineering
5.3.4 Vaccine Design
5.3.5 Therapeutics Antibodies
5.3.6 Others
5.4 Global Gene Synthesis Market by Gene Synthesis Type
5.4.1 Market Overview
5.4.2 Gene Library Synthesis
5.4.3 Solid Phase Synthesis
5.4.4 Chip-Based DNA Synthesis
5.4.5 PCR-Based Enzyme Synthesis
5.5 Global Gene Synthesis Market by Region
5.5.1 Market Overview
5.5.2 North America
5.5.3 Europe
5.5.4 Asia Pacific
5.5.5 Latin America
5.5.6 Middle East and Africa
6 North America Gene Synthesis Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Gene Synthesis Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Gene Synthesis Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America Gene Synthesis Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Gene Synthesis Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Regulatory Framework
11.1 Regulatory Overview
11.1.1 US FDA
11.1.2 EU EMA
11.1.3 INDIA CDSCO
11.1.4 JAPAN PMDA
11.1.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 ATDBio Ltd
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 General Biosystems
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Macrogen CO.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Boster Biological Technology
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Creative Biogene
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Bioneer Pacific,
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Exonbio
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 trenzyme GmbH
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Twist Bioscience
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 BioCat GmbH
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 OriGene Technologies, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Integrated DNA Technologies
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Eurofins Scientific
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 NZYTech
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Genes and Enzymes
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.